Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick C Souverein

Showing results (1-10 of 140) with videos related to

Pageof 14
Sort By:
Open Heart|August 26, 2025
Sodium-glucose cotransporter-2 inhibitors and the risk of all-cause mortality: a population-based cohort study using the UK Clinical Practice Research DatalinkTalip E Eroglu, Ruben Coronel, Patrick C Souverein
European Heart Journal. Cardiovascular Pharmacotherapy|March 23, 2024
Sodium-glucose cotransporter-2 inhibitors and the risk of atrial fibrillation in patients with type 2 diabetes: a population-based cohort studyTalip E Eroglu, Ruben Coronel, Patrick C Souverein
Thrombosis and Haemostasis|January 10, 2009
Effect of oral antiplatelet agents on major bleeding in users of coumarinsTom Schalekamp, Olaf H Klungel, Patrick C Souverein, et al.
Journal of Clinical Pharmacy and Therapeutics|April 9, 2019
Risk of myocardial infarction associated with non-steroidal anti-inflammatory drugs: Impact of additional confounding control for variables collected from self-reported dataMohammad Bakhriansyah, Patrick C Souverein, Anthonius de Boer, et al.
Archives of Internal Medicine|January 30, 2008
Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarinsTom Schalekamp, Olaf H Klungel, Patrick C Souverein, et al.
Pharmacoepidemiology and Drug Safety|April 4, 2017
Gastrointestinal toxicity among patients taking selective COX-2 inhibitors or conventional NSAIDs, alone or combined with proton pump inhibitors: a case-control studyMohammad Bakhriansyah, Patrick C Souverein, Anthonius de Boer, et al.
Journal of Clinical Epidemiology|November 3, 2009
Construction of drug treatment episodes from drug-dispensing histories is influenced by the gap lengthHelga Gardarsdottir, Patrick C Souverein, Toine C G Egberts, et al.
The Annals of Pharmacotherapy|June 1, 2006
Difference in risks of allergic reaction to sulfonamide drugs based on chemical structureB Marianne Verdel, Patrick C Souverein, Antoine Cg Egberts, et al.
Journal of Psychopharmacology (Oxford, England)|April 7, 2022
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and risk of depression among older people with hypertensionThomas T van Sloten, Patrick C Souverein, Coen DA Stehouwer, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 18, 2021
Multiple categories of non-cardiac QT-prolonging drugs are associated with increased risk of out-of-hospital cardiac arrest: real-world data from a population-based studyTalip E Eroglu, Marieke T Blom, Patrick C Souverein, et al.
Pageof 14

Showing results (1-10 of 140) with videos related to

Sort By:
Pageof 14
Open Heart|August 26, 2025
Sodium-glucose cotransporter-2 inhibitors and the risk of all-cause mortality: a population-based cohort study using the UK Clinical Practice Research DatalinkTalip E Eroglu, Ruben Coronel, Patrick C Souverein
European Heart Journal. Cardiovascular Pharmacotherapy|March 23, 2024
Sodium-glucose cotransporter-2 inhibitors and the risk of atrial fibrillation in patients with type 2 diabetes: a population-based cohort studyTalip E Eroglu, Ruben Coronel, Patrick C Souverein
Thrombosis and Haemostasis|January 10, 2009
Effect of oral antiplatelet agents on major bleeding in users of coumarinsTom Schalekamp, Olaf H Klungel, Patrick C Souverein, et al.
Journal of Clinical Pharmacy and Therapeutics|April 9, 2019
Risk of myocardial infarction associated with non-steroidal anti-inflammatory drugs: Impact of additional confounding control for variables collected from self-reported dataMohammad Bakhriansyah, Patrick C Souverein, Anthonius de Boer, et al.
Archives of Internal Medicine|January 30, 2008
Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarinsTom Schalekamp, Olaf H Klungel, Patrick C Souverein, et al.
Pharmacoepidemiology and Drug Safety|April 4, 2017
Gastrointestinal toxicity among patients taking selective COX-2 inhibitors or conventional NSAIDs, alone or combined with proton pump inhibitors: a case-control studyMohammad Bakhriansyah, Patrick C Souverein, Anthonius de Boer, et al.
Journal of Clinical Epidemiology|November 3, 2009
Construction of drug treatment episodes from drug-dispensing histories is influenced by the gap lengthHelga Gardarsdottir, Patrick C Souverein, Toine C G Egberts, et al.
The Annals of Pharmacotherapy|June 1, 2006
Difference in risks of allergic reaction to sulfonamide drugs based on chemical structureB Marianne Verdel, Patrick C Souverein, Antoine Cg Egberts, et al.
Journal of Psychopharmacology (Oxford, England)|April 7, 2022
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and risk of depression among older people with hypertensionThomas T van Sloten, Patrick C Souverein, Coen DA Stehouwer, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 18, 2021
Multiple categories of non-cardiac QT-prolonging drugs are associated with increased risk of out-of-hospital cardiac arrest: real-world data from a population-based studyTalip E Eroglu, Marieke T Blom, Patrick C Souverein, et al.
Pageof 14